Trade Harvard Bioscience - HBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0185 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.5828 |
| Open | 0.5628 |
| 1-Year Change | -86.69% |
| Day's Range | 0.5628 - 0.5841 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | 0.5828 | -0.0176 | -2.93% | 0.6004 | 0.6004 | 0.5528 |
| Mar 31, 2025 | 0.5582 | -0.0334 | -5.65% | 0.5916 | 0.5916 | 0.5582 |
| Mar 28, 2025 | 0.5928 | 0.0150 | 2.60% | 0.5778 | 0.6034 | 0.5778 |
| Mar 27, 2025 | 0.5927 | -0.0072 | -1.20% | 0.5999 | 0.6028 | 0.5769 |
| Mar 26, 2025 | 0.6039 | 0.0211 | 3.62% | 0.5828 | 0.6061 | 0.5728 |
| Mar 25, 2025 | 0.5849 | -0.0069 | -1.17% | 0.5918 | 0.5918 | 0.5478 |
| Mar 24, 2025 | 0.5830 | -0.0498 | -7.87% | 0.6328 | 0.6428 | 0.5828 |
| Mar 21, 2025 | 0.6213 | -0.0165 | -2.59% | 0.6378 | 0.6378 | 0.6028 |
| Mar 20, 2025 | 0.6454 | -0.0374 | -5.48% | 0.6828 | 0.6829 | 0.6371 |
| Mar 19, 2025 | 0.6846 | -0.0082 | -1.18% | 0.6928 | 0.7027 | 0.6638 |
| Mar 18, 2025 | 0.6665 | -0.0063 | -0.94% | 0.6728 | 0.6962 | 0.6558 |
| Mar 17, 2025 | 0.6923 | 0.0351 | 5.34% | 0.6572 | 0.7063 | 0.6130 |
| Mar 14, 2025 | 0.6408 | -0.0123 | -1.88% | 0.6531 | 0.6531 | 0.5928 |
| Mar 13, 2025 | 0.6327 | -0.0601 | -8.67% | 0.6928 | 0.6928 | 0.6327 |
| Mar 12, 2025 | 0.6608 | -0.0520 | -7.30% | 0.7128 | 0.7128 | 0.6165 |
| Mar 11, 2025 | 0.7578 | -0.0050 | -0.66% | 0.7628 | 0.7730 | 0.7516 |
| Mar 10, 2025 | 0.7678 | -0.0251 | -3.17% | 0.7929 | 0.7939 | 0.7628 |
| Mar 7, 2025 | 0.8049 | -0.0015 | -0.19% | 0.8064 | 0.8258 | 0.8028 |
| Mar 6, 2025 | 0.8166 | 0.0120 | 1.49% | 0.8046 | 0.8205 | 0.7728 |
| Mar 5, 2025 | 0.7969 | 0.0046 | 0.58% | 0.7923 | 0.8193 | 0.7749 |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group710K+
Traders
110K+
Active clients monthly
$214B+
Monthly trading volume
$55M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Harvard Bioscience Company profile
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms, and clinical. The Company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The Company’s customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Harvard Bioscience, Inc. revenues increased 16% to $118.9M. Net loss decreased 96% to $288K. Revenues reflect United States segment increase of 18% to $49.8M, Europe segment increase of 19% to $35.8M. Lower net loss reflects Interest expense decrease of 68% to $1.5M (expense), G/L on early Exting of lease relat debt decrease from $1.9M (expense) to $0K.
Equity composition
Common Stock $.01 Par, 12/10, 80M auth., 36,057,974 issd., less 7,745,507 shs. in Treas. @ 10.7M. Insiders & Strategic holders own 13.56%. IPO: 12/7/2000, 6,420,000 shs. @$8 by Thomas Weisel Partners LLC. *NOTE: 10/02, Company acquired Genomic Solutions, Inc. @ 0.1017 shares and $0.286 in cash (3,178,857 shares issd.).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
84 October Hill Rd
HOLLISTON
MASSACHUSETTS 01746-1371
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com